Literature DB >> 26109178

Coexistence of Andersen-Tawil Syndrome with Polymorphisms in hERG1 Gene (K897T) and SCN5A Gene (H558R) in One Family.

Michalina Jagodzińska1, Małgorzata Szperl2, Joanna Ponińska2, Agnieszka Kosiec2, Robert Gajda3, Piotr Kukla4, Elżbieta Katarzyna Biernacka5.   

Abstract

BACKGROUND: Andersen-Tawil Syndrome (ATS) is a channelopathy caused by mutations in KCNJ2 gene. It is characterized by symptoms of ventricular arrhythmias, periodic paralysis or muscle weakness, and dysmorphic features. ATS can present with the triad of symptoms, any combination or none of them. Risk factors for dangerous arrhythmias are unknown. The study assessed the impact of K897T polymorphism in hERG1 gene and H558R polymorphism in SCN5A gene coexisting with R218Q mutation in KCNJ2 in one family on clinical manifestation.
METHODS: Family members underwent clinical assessment, ECG and genotyping. Holter monitoring was performed in mutation carriers and additionally in one family member with no mutation, but with K897T polymorphism.
RESULTS: Proband with ATS mutation, K897T and H558R polymorphisms and proband's sister with ATS mutation and K897T polymorphism presented following symptoms: loss of consciousness, bidirectional and polymorphic ventricular tachycardia and about 5000 ventricular extrasystoles. Symptoms presented by the member with only the ATS mutation and by member with ATS mutation and H558R polymorphism were not as severe. U wave appeared in all examined family members regardless of the mutation presence. Studied individuals with ATS mutation had the T-peak-U-peak interval longer than 200 ms. In all ATS mutation carriers it was longer than in family members with no mutation. T-peak-T-end interval was the longest (>120 ms) in members with coexisting mutation and K897T polymorphism.
CONCLUSION: ATS severity possibly depends on other genes' polymorphisms. In the presented family, it could depend on the presence of K897T polymorphism in hERG1.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  clinical; electrophsiology-long QT syndrome; molecular biology/genetics basic

Mesh:

Substances:

Year:  2015        PMID: 26109178      PMCID: PMC6931717          DOI: 10.1111/anec.12283

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  20 in total

Review 1.  From molecule to malady.

Authors:  Frances M Ashcroft
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

2.  Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.

Authors:  N M Plaster; R Tawil; M Tristani-Firouzi; S Canún; S Bendahhou; A Tsunoda; M R Donaldson; S T Iannaccone; E Brunt; R Barohn; J Clark; F Deymeer; A L George; F A Fish; A Hahn; A Nitu; C Ozdemir; P Serdaroglu; S H Subramony; G Wolfe; Y H Fu; L J Ptácek
Journal:  Cell       Date:  2001-05-18       Impact factor: 41.582

Review 3.  The primary periodic paralyses: diagnosis, pathogenesis and treatment.

Authors:  S L Venance; S C Cannon; D Fialho; B Fontaine; M G Hanna; L J Ptacek; M Tristani-Firouzi; R Tawil; R C Griggs
Journal:  Brain       Date:  2005-09-29       Impact factor: 13.501

4.  PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome.

Authors:  M R Donaldson; J L Jensen; M Tristani-Firouzi; R Tawil; S Bendahhou; W A Suarez; A M Cobo; J J Poza; E Behr; J Wagstaff; P Szepetowski; S Pereira; T Mozaffar; D M Escolar; Y-H Fu; L J Ptácek
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

5.  Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women.

Authors:  Eeva Pietilä; Heidi Fodstad; Elmo Niskasaari; Päivi J Laitinen P; Heikki Swan; Markku Savolainen; Y Antero Kesäniemi; Kimmo Kontula; Heikki V Huikuri
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

6.  KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes.

Authors:  Gregor Andelfinger; Andrew R Tapper; Richard C Welch; Carlos G Vanoye; Alfred L George; D Woodrow Benson
Journal:  Am J Hum Genet       Date:  2002-07-29       Impact factor: 11.025

7.  Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study.

Authors:  Christopher Newton-Cheh; Chao-Yu Guo; Martin G Larson; Stacy L Musone; Aarti Surti; Amy L Camargo; Jared A Drake; Emelia J Benjamin; Daniel Levy; Ralph B D'Agostino; Joel N Hirschhorn; Christopher J O'donnell
Journal:  Circulation       Date:  2007-08-20       Impact factor: 29.690

Review 8.  Factor V Leiden thrombophilia.

Authors:  Jody Lynn Kujovich
Journal:  Genet Med       Date:  2011-01       Impact factor: 8.822

Review 9.  Congenital long QT syndrome.

Authors:  Lia Crotti; Giuseppe Celano; Federica Dagradi; Peter J Schwartz
Journal:  Orphanet J Rare Dis       Date:  2008-07-07       Impact factor: 4.123

Review 10.  Regulatory Variants and Disease: The E-Cadherin -160C/A SNP as an Example.

Authors:  Gongcheng Li; Tiejun Pan; Dan Guo; Long-Cheng Li
Journal:  Mol Biol Int       Date:  2014-09-02
View more
  3 in total

Review 1.  Coincidence of Andersen-Tawil syndrome and Marfan syndrome: A case report.

Authors:  Michalina Krych; Joanna Ponińska; Zofia T Bilińska; Rafał Płoski; Elżbieta K Biernacka
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-01-23       Impact factor: 1.468

2.  Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.

Authors:  Michalina Krych; Elżbieta Katarzyna Biernacka; Joanna Ponińska; Piotr Kukla; Artur Filipecki; Robert Gajda; Can Hasdemir; Charles Antzelevitch; Agnieszka Kosiec; Małgorzata Szperl; Rafał Płoski; Maria Trusz-Gluza; Katarzyna Mizia-Stec; Piotr Hoffman
Journal:  J Cardiol       Date:  2017-03-21       Impact factor: 3.159

3.  Amateur Athlete with Sinus Arrest and Severe Bradycardia Diagnosed through a Heart Rate Monitor: A Six-Year Observation-The Necessity of Shared Decision-Making in Heart Rhythm Therapy Management.

Authors:  Robert Gajda; Beat Knechtle; Anita Gębska-Kuczerowska; Jacek Gajda; Sebastian Stec; Michalina Krych; Magdalena Kwaśniewska; Wojciech Drygas
Journal:  Int J Environ Res Public Health       Date:  2022-08-19       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.